REMODULIN® - Bioprojet
2118
portfolio_page-template-default,single,single-portfolio_page,postid-2118,bridge-core-2.9.3,,qode_grid_1200,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-27.7,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.7.0,vc_responsive
 

REMODULIN®

REMODULIN®

TREPROSTINIL (solution for perfusion)

Treatment of idiopathic or hereditary pulmonary hypertension in view of improving exercise tolerance and disease symptoms in New York Heart Association (NYHA) functional class III patients.

Useful links

French Healthcare Authority
has-sante.fr